Publications | PubMed=2982333 Terashima M., Inoue K., Mukaiyama T., Mitsui I., Ogawa M. Enhanced cytotoxic effect of adriamycin and vincristine against PC-6 (human lung cancer cell line) and Hattori (human breast cancer cell line). Gan To Kagaku Ryoho 12:343-347(1985) PubMed=3731100 Hanai N., Shitara K., Yoshida H. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung. Cancer Res. 46:4438-4443(1986) PubMed=9259410; DOI=10.1002/(SICI)1097-0215(19970807)72:4<680::AID-IJC21>3.0.CO;2-E Joto N., Ishii M., Minami M., Kuga H., Mitsui I., Tohgo A. DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant. Int. J. Cancer 72:680-686(1997) PubMed=10912951; DOI=10.1097/00001813-200006000-00005 Ishii M., Iwahana M., Mitsui I., Minami M., Imagawa S., Tohgo A., Ejima A. Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6. Anticancer Drugs 11:353-362(2000) PubMed=12107105; DOI=10.1016/S0002-9440(10)64172-7; PMCID=PMC1850681 Yokoi S., Yasui K., Saito-Ohara F., Koshikawa K., Iizasa T., Fujisawa T., Terasaki T., Horii A., Takahashi T., Hirohashi S., Inazawa J. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am. J. Pathol. 161:207-216(2002) PubMed=15185009; DOI=10.1007/s00262-004-0533-9; PMCID=PMC11034254 Yamaji H., Iizasa T., Koh E., Suzuki M., Otsuji M., Chang H., Motohashi S., Yokoi S., Hiroshima K., Tagawa M., Nakayama T., Fujisawa T. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer. Cancer Immunol. Immunother. 53:786-792(2004) PubMed=17237272; DOI=10.1158/1535-7163.MCT-06-0529 Oguri T., Bessho Y., Achiwa H., Ozasa H., Maeno K., Maeda H., Sato S., Ueda R. MRP8/ABCC11 directly confers resistance to 5-fluorouracil. Mol. Cancer Ther. 6:122-127(2007) PubMed=17511773; DOI=10.1111/j.1349-7006.2007.00507.x; PMCID=PMC11159702 Fukuyama T., Ichiki Y., Yamada S., Shigematsu Y., Baba T., Nagata Y., Mizukami M., Sugaya M., Takenoyama M., Hanagiri T., Sugio K., Yasumoto K. Cytokine production of lung cancer cell lines: correlation between their production and the inflammatory/immunological responses both in vivo and in vitro. Cancer Sci. 98:1048-1054(2007) PubMed=18445659; DOI=10.1158/1535-7163.MCT-07-2088 Oguri T., Ozasa H., Uemura T., Bessho Y., Miyazaki M., Maeno K., Maeda H., Sato S., Ueda R. MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer. Mol. Cancer Ther. 7:1150-1155(2008) PubMed=21128075; DOI=10.1007/s00280-010-1533-4 Takakuwa O., Oguri T., Ozasa H., Uemura T., Kasai D., Miyazaki M., Maeno K., Sato S. Over-expression of MDR1 in amrubicinol-resistant lung cancer cells. Cancer Chemother. Pharmacol. 68:669-676(2011) |